Union Bancaire Privee UBP SA Acquires 8,744 Shares in Quest Diagnostics

The firm bought a new position in the medical research company's stock during the fourth quarter.

Mar. 22, 2026 at 11:14am

Got story updates? Submit your updates here. ›

Union Bancaire Privee UBP SA bought a new position in shares of Quest Diagnostics Incorporated (NYSE:DGX) during the fourth quarter, according to the company's recent 13F filing with the Securities and Exchange Commission. The firm acquired 8,744 shares of the medical research company's stock, valued at approximately $1,517,000.

Why it matters

This transaction highlights the continued interest and investment in Quest Diagnostics, a leading provider of diagnostic information services, by institutional investors like Union Bancaire Privee UBP SA. The acquisition reflects the firm's belief in the company's growth potential and market position.

The details

According to the 13F filing, Union Bancaire Privee UBP SA bought 8,744 shares of Quest Diagnostics stock during the fourth quarter. This new position is valued at approximately $1,517,000 based on the company's stock price at the time.

  • The transaction occurred during the fourth quarter of the year.

The players

Union Bancaire Privee UBP SA

A Swiss private bank that manages assets for high-net-worth individuals, families, and institutions.

Quest Diagnostics Incorporated

An American clinical laboratory company that provides diagnostic information services, including core clinical laboratory testing, anatomic pathology, molecular and genomic testing, and infectious disease testing.

Got photos? Submit your photos here. ›

The takeaway

This acquisition by Union Bancaire Privee UBP SA demonstrates the continued investor confidence in Quest Diagnostics' business model and growth prospects within the medical diagnostics industry.